Neuroprotection in Acute Ischemic Stroke

Completed

Phase N/A Results

Summary of Purpose

To assess the efficacy and safety of adjuvant treatment with Cerebolysin (CERE) in acute stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 December 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Multi-center, double-blind, placebo-controlled study of 146 patients.

Contacts

Not available